The FDA has authorized Merck's COVID pill for home use — the second in two days

·

·

The FDA has authorized Merck's COVID pill for home use — the second in two days

The U.S. Food and Drug Administration has authorized the second antiviral pill to treat COVID-19 at home. The medicine, called molnupiravir and made by Merck and Ridgeback Biotherapeutics, is taken twice a day for five days. Merck says it will have 10 …
See Original Article

4 in 5 UK SMEs aren't seeking finance to grow, ACCA finds | News – Accountancy Today

The data reveals that accountants believe more than one in four businesses have still not returned to pre-Covid levels of productivity or turnover
See Original Article

Cost Accounting Software Market Investment Analysis – CyclicMint

Global Cost Accounting Software Market (Pre-Post Covid-19) Size & Forecast Analysis till 2029: Global Cost Accounting Software research rep.
See Original Article

Intel (INTC) to Expand in France, Germany and Italy in Comeback Effort – Bloomberg

The Intel headquarters in Santa Clara, California, U.S. Photographer: David Paul Morris/Bloomberg. SHARE THIS ARTICLE.
See Original Article

Teladoc Stock: Is Cathie Wood's Meme Stock a Buy? – TheStreet

It's also the third-largest holding on the ARK Innovation ETF (ARKK) – Get ARK Innovation ETF Report, accounting for 6.5% of the fund and sitting
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.